KALC 2024 INTERNATIONAL CONFERENCE NOVEMBER 7THU ~ 8FRI, 2024 LOTTE HOTEL WORLD, SEOUL, KOREA
KALC 2024 INTERNATIONAL CONFERENCE NOVEMBER 7THU ~ 8FRI, 2024 LOTTE HOTEL WORLD, SEOUL, KOREA
24년도 대한폐암학회 연회비를 납부하셔야 회원가로 등록이 가능합니다. 연회비 납부하시겠습니까?
Oral Presentation 1
Abstract No. | Presentation Time | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0186 | 14:45-14:55 | Spatial transcriptomics reveals spatially diverse cancer-associated fibroblasts in lung squamous cell carcinoma linked to tumor progression | Kwon Joong Na | Seoul National University | Korea |
A-0184 | 14:55-15:05 | Single-cell RNA sequencing revealed that changes in monocytes are involved in the prognosis of durvalumab consolidation therapy following chemoradiotherapy | Duk Ki Kim | Chungnam National University | Korea |
A-0105 | 15:05-15:15 | Landscape of tumor heterogeneity and tumor mutational burden (TMB) in non-small cell lung cancer (NSCLC) | Jong Yeob Kim | Feinberg School of Medicine, Northwestern University | USA |
A-0127 | 15:15-15:25 | Induction of malignant transformation in human bronchial epithelial cells and lung organoids by chronic exposure to whole cigarette smoke extract | Chaeuk Chung | Chungnam National University | Korea |
A-0057 | 15:25-15:35 | Identification of GREM-1 and GAS6 as specific biomarkers for cancer-associated fibroblasts derived from patients with non-small cell lung cancer | Bo-Guen Kim | Kangbuk Samsung Medical Center | Korea |
A-0042 | 15:35-15:45 | Spatially defined co-culture model of non-small cell lung cancer organoids and cancer-associated fibroblasts to investigate phenotypic heterogeneity | Cheol-Kyu Park | Chonnam National University | Korea |
Oral Presentation 2
Abstract No. | Presentation Time | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0226 | 09:10-09:20 | Perioperative outcomes of neoadjuvant chemoimmunotherapy followed by surgery in stage II-III NSCLC: A real-world study | Junghee Lee | Samsung Medical Center | Korea |
A-0214 | 09:20-09:30 | Preliminary analysis of lazertinib consolidation therapy in patients with locally advanced, unresectable, EGFR mutated NSCLC following chemoradiation therapy: PLATINUM trial | Sung Yong Lee | Korea University | Korea |
A-0204 | 09:30-09:40 | What Is the Optimal Dose and Fractionation Schedule for Inoperable Node-Negative Large (>5 cm) Non-Small Cell Lung Cancer? | Ye Jin Yoo | Asan Medical Center | Korea |
A-0108 | 09:40-09:50 | Double lung transplantation in patients with metastatic lung-limited non-small cell lung carcinoma (NSCLC): A case series | Young Chae | Northwestern University Feinberg School of Medicine | USA |
A-0069 | 09:50-10:00 | Normal brain-sparing radiotherapy versus whole brain radiotherapy for multiple brain metastasis from non-small cell lung cancer | Sangjoon Park | Severance Hospital | Korea |
A-0046 | 10:00-10:10 | Refining patient selection for prophylactic cranial irradiation in limited-stage small-cell lung cancer: Insights from a Korean multi-institutional cohort study | Hye In Lee | Asan Medical Center | Korea |
Oral Presentation 3
Abstract No. | Presentation Time | Abstract Title | Presenter Name | Affiliation | Country |
---|---|---|---|---|---|
A-0080 | 10:25-10:35 | Real-world insights: Treatment patterns and overall survival in patients with small-cell lung cancer in South Korea a single center experience | Sehhoon Park | Samsung Medical Center, Sungkyunkwan University School of Medicine | Korea |
A-0196 | 10:35-10:45 | AI-powered pathologic response evaluation of post-neoadjuvant chemoimmunotherapy in NSCLC patients | Kwon Joong Na | Seoul National University | Korea |
A-0167 | 10:45-10:55 | Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-Expressing platelets in lung cancer patients | Jae Ho Cho | Chonnam National University Medical School | Korea |
A-0230 | 10:55-11:05 | Chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer with actionable gene alterations other than EGFR, ALK, and ROS1 | Ji Eun Shin | The Catholic University of Korea St. Vincent's Hospital | Korea |
A-0131 | 11:05-11:15 | Sequential hypofractionated radiotherapy followed by anti-PD-L1 atezolizumab for recurrent or refractory small cell lung cancer | Yang-Gun Suh | National Cancer Center | Korea |
A-0035 | 11:15-11:25 | Imaging trajectory of transformation into small-cell carcinomas from lung adenocarcinomas undergoing TKI treatment: radiomic prediction | Jihwan Choi | Samsung Medical Center | Korea |